The NIH Cardiovascular Bioengineering Symposium, 1-2 March 2019, Sydney, Australia

[Site in Test Mode]

It is with great pleasure that we announce that the fifth NIH Progenitor Cell Translational Consortium (PCTC) Cardiovascular Bioengineering (CVBE 2019) Symposium will be held in Sydney, Australia on the 1st and 2nd of March 2019. The two day meeting will bring together a faculty of internationally leading scientists from North America, Europe, USA, Asia and Australia. We will cover a spectrum of fundamental and translational topics related to the fields of cardiac cell therapy, cardiovascular sciences, bioengineering and stem cell biology.

Confirmed Invited Speakers

We have been fortunate to attract a truly stellar panel of invited speakers, including: Philippe Menasche, Michael Laflamme, Nenad Bursac, Bob Graham, Keiichi Fukuda, Åsa Gustafsson, Timothy J. Kamp, Enzo Porrello, Burns C. Blaxall, Denis Buxton, Richard Harvey, Rong Tian, Li Qian, Lei Ye, James Hudson, Anna Waterhouse, Florian Weinberger, Xinyang Hu, Yuji Shiba, Hong Wang, Maria Kontaridis, Jelena Rnjak-Kovacina, Song Li and Teng Ma.
And there are more to follow, stay tuned!

We are also delighted that Prof Victor J. Dzau, MD has accepted our invitation to give our Keynote Lecture on the Paracrine mechanism of stem cell therapy.

As one of the world’s preeminent health leaders, Dr. Dzau advises governments, corporations, and universities worldwide. He has served as a member of the Advisory Committee to the Director of the National Institutes of Health (NIH) and as Chair of the NIH Cardiovascular Disease Advisory Committee. Currently he is a member of the Board of the Singapore Health System and Hamad Medical Corporation, Qatar. He was on the Board of Health Governors of the World Economic Forum and chaired its Global Agenda Council on Personalized and Precision Medicine.

Among his many honors and recognitions are the Gustav Nylin Medal from the Swedish Royal College of Medicine, the Distinguished Scientist Award from the American Heart Association, Ellis Island Medal of Honor, and the Henry Freisen International Prize. In 2014, he received the Public Service Medal from the President of Singapore. He is a member of the Institute of Medicine of the National Academy of Sciences, the American Academy of Arts and Sciences and the European Academy of Sciences and Arts. He has received eight honorary doctorates.

This is the first time that the Symposium has been held in Australia and we hope that you'll be able to join us in celebrating this landmark event.

James Chong Jay Zhang
James Chong, University of Sydney, Australia
Jay Zhang, UAB, USA

Conference Convenors